Risk score for outcome after allogeneic hematopoietic stem cell transplantation : A Retrospective Analysis
✍ Scribed by Alois Gratwohl; Martin Stern; Ronald Brand; Jane Apperley; Helen Baldomero; Theo de Witte; Giorgio Dini; Vanderson Rocha; Jakob Passweg; Anna Sureda; André Tichelli; Dietger Niederwieser; for the European Group for Blood; Marrow Transplantation; the European Leukemia Net
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 270 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A total of 149 patients with multiple myeloma (MM) who received allogeneic hematopoietic stem cell transplantation (allo‐HCT) with myeloablative (MAC; __n__ = 38) or reduced‐intensity conditioning (RIC; __n__ = 110) regimens at MD Anderson Cancer Center were evaluated. Of the total, 120
## Abstract In recent years, many studies have confirmed that allogeneic stem cell transplantation (allo‐SCT) can provide long‐term disease control and possible cure in selected patients with chronic lymphocytic leukaemia (CLL), including those with a biologically highly unfavourable risk profile.